PharmaNet Demonstrates Commitment to Supporting Public Education Worldwide
The Center for Information and Study on Clinical Research Participation (CISCRP) recognized PharmaNet as this year?s award recipient for ?Supporting the Development of Educational Materials.?
PharmaNet Demonstrates Commitment to Supporting Public Education Worldwide
Boston, MA, June 30, 2008- On Monday June 23, 2008, the Center for Information and Study on Clinical Research Participation (CISCRP) held their 2008 Annual Meeting. Board Chairman, Ken Getz, and President & CEO Diane Simmons, recognized PharmaNet as this year’s award recipient for “Supporting the Development of Educational Materials.” Through their collaboration with CISCRP, a 501(c)(3) nonprofit, PharmaNet made possible the development of country-specific brochures that educate the public about the risks and benefits of volunteering for clinical research studies. Since patient protections and resources are not uniform across the globe, PharmaNet addressed this issue through their support of educational tools that identify government, disease-specific, and industry resources for residents of 12 different nations including: Argentina, Brazil, Canada (French speaking), Czech Republic, France, Germany, Italy, Mexico, Poland, Russia, Spain, and the Ukraine.
Accepting the award on behalf of PharmaNet’s Clinical Recruitment Group was Christine Rhoda, Senior Director, Clinical Research from PharmaNet’s Boston office. According to Ms. Rhoda, “Anybody who is participating in a clinical trial, no matter what part of the world, needs to be adequately informed about participation.” All the attendees at the CISCRP Annual Meeting applauded PharmaNet for helping to address this critical issue.
About PharmaNet - a global, drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. In addition, PharmaNet offers technology tools for managing clinical trial data.
About CISCRP-a non-profit organization located in Dedham, MA that is focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting patients for clinical trials nor is it involved in conducting clinical trials.
Contact: Elena Gallagher or Meaghan Dunn, CISCRP
Phone: (781) 326-3400
Fax: (781) 326-3420
Email: [email protected]; [email protected]
Website: www.ciscrp.org
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
